BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of investors of ChromaDex Corporation (“ChromaDex” or the “Company”) (NASDAQ: CDXC) concerning the Company and its officers’ possible violations of federal securities laws.
ChromaDex is a natural products company that purportedly, through its subsidiaries, discovers, acquires, develops and commercializes patented and proprietary ingredient technologies.
On June 20, 2016, Bleecker Street Research (“Bleecker”) published a report accusing ChromaDex shareholder Barry Honig of using hidden ownership, undisclosed stock sales, installed puppet CEOs, and false press releases in connection with fraudulent stock promotions. The report asserts that Honig is doing something similar with ChromaDex. Moreover, Bleecker claims ChromaDex’s profitability for the first quarter of 2016 is likely fabricated and “appears to be engineered.”
On this news, shares of ChromaDex fell over 40% to close at just $2.84 on June 20, 2016.
If you purchased ChromaDex securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.